Latest Options News

InFocus Group Holdings has completed Codexa, a proprietary sweepstakes casino platform targeting the booming US market, with plans for licensing and potential sale.

Radiopharm Theranostics has initiated dosing in its Phase 1 clinical trial of RAD 402, a novel radiolabelled antibody targeting KLK3 in advanced prostate cancer. Early data from the trial’s initial dose levels are expected in the second half of 2026.

Winsome Resources Limited is set to be acquired by Li-FT Power Ltd through a scheme of arrangement, consolidating key lithium assets and creating a dual-listed entity on ASX and TSXV.

Eminence Minerals has completed the divestment of its Alturas Antimony Project to Maxus Mining, receiving cash and shares that bolster its balance sheet while maintaining exposure to antimony.

Redivium Limited advances its recapitalisation efforts and project development despite ASX suspension, withdrawing its European Green Bond and exploring new UK site options.

Gowing Bros Limited has announced a fully franked ordinary dividend of AUD 0.03 per share for the half-year ending January 2026, alongside a Dividend Reinvestment Plan offering shareholders a choice to reinvest without discount.

Omni Bridgeway Limited has released a comprehensive analyst data pack showcasing its robust 40-year track record, diversified global portfolio, and strategic growth plans in the legal finance sector.

Iceni Gold has upsized its recent placement to nearly $1.76 million, securing additional funds to advance drilling and exploration at its flagship 14 Mile Well Gold Project in Western Australia.

Thrive Tribe Technologies has completed a $240,554 capital raise through a discounted share placement, aiming to bolster its working capital. The placement involved issuing over 318 million shares at a 25% discount, with Clee Capital acting as lead manager.

Lachlan Star Limited has appointed mining veteran Tony Kiernan as independent Non-Executive Chairman alongside Alan Thom as Non-Executive Director, marking a strategic board refresh aimed at accelerating the company’s growth in Western Australia’s gold sector.

BCAL Diagnostics is expanding access to its Avantect pancreatic and ovarian cancer blood tests across Australia through partnerships with major pathology providers. This move marks a significant step in making early cancer detection more widely available.

Cobre Limited’s Chilean subsidiary has secured a majority stake and operational control of the Sierra Atacama Copper Project, setting the stage for potential full ownership through staged acquisitions and strategic governance changes.